Skip to main content Back to Top
Advertisement

5/26/2016

Pantoprazole Tablets

Products Affected - Description

    • Pantoprazole tablet, Actavis, 40 mg, 1000 count, NDC 45963-0570-05
    • Pantoprazole tablet, Caraco, 40 mg, 90 count, NDC 47335-0580-81
    • Pantoprazole tablet, Kremers Urban, 20 mg, 90 count, NDC 62175-0180-46
    • Pantoprazole tablet, Major, 40 mg, 100 count, NDC 00904-6235-61
    • Pantoprazole tablet, Prasco, 20 mg, 90 count, NDC 00008-0606-01
    • Pantoprazole tablet, Prasco, 40 mg, 90 count, NDC 00008-0607-01
    • Pantoprazole tablet, Prasco, 40 mg, unit-dose 100 count, NDC 00008-0607-04
    • Pantoprazole tablet, Teva, 40 mg, 90 count, NDC 00093-0012-98

Reason for the Shortage

    • Aurobindo and Teva could not provide a reason for the shortage.
    • Actavis discontinued pantoprazole 20 mg tablets in October 2014.
    • Caraco has a new NDC number for pantoprazole 40 mg tablets.
    • Kremers Urban state the shortage is due to increased demand.
    • FDA imposed an import ban in mid-2013 on several Wockhardt products including pantoprazole.
    • Major has a new NDC number for pantoprazole 40 mg tablets.

Available Products

    • Protonix tablet, Pfizer, 20 mg, 90 count, NDC 00008-0843-81
    • Protonix tablet, Pfizer, 40 mg, 90 count, NDC 00008-0841-81
    • Protonix tablet, Pfizer, 40 mg, 100 count, NDC 00008-0841-99
    • Pantoprazole tablet, Actavis, 40 mg, 90 count, NDC 45963-0570-08
    • Pantoprazole tablet, Aurobindo, 20 mg, 90 count, NDC 65862-0559-90
    • Pantoprazole tablet, Aurobindo, 40 mg, 90 count, NDC 65862-0560-90
    • Pantoprazole tablet, Cadista, 20 mg, 90 count, NDC 59746-0283-90
    • Pantoprazole tablet, Cadista, 40 mg, 90 count, NDC 59746-0284-90
    • Pantoprazole tablet, Camber, 20 mg, 90 count, NDC 31722-0712-90
    • Pantoprazole tablet, Camber, 40 mg, 90 count, NDC 31722-0713-90
    • Pantoprazole tablet, Caraco, 40 mg, 90 count, NDC 62756-0580-81
    • Pantoprazole tablet, Dr. Reddy's, 20 mg, 90 count, NDC 55111-0332-90
    • Pantoprazole tablet, Dr. Reddy's, 40 mg, 90 count, NDC 55111-0333-90
    • Pantoprazole tablet, Kremers Urban, 40 mg, 90 count, NDC 62175-0617-46
    • Pantoprazole tablet, Kremers Urban, 40 mg, 1000 count, NDC 62175-0617-43
    • Pantoprazole tablet, Major, 40 mg, 100 count, NDC 00904-6474-61
    • Pantoprazole tablet, Mylan, 20 mg, 90 count, NDC 00378-6688-77
    • Pantoprazole tablet, Mylan, 40 mg, 90 count, NDC 00378-6689-77
    • Pantoprazole tablet, Mylan, 40 mg, 1000 count, NDC 00378-6689-10
    • Pantoprazole tablet, Mylan Institutional, 40 mg, 100 count, NDC 51079-0051-20
    • Pantoprazole tablet, Teva, 20 mg, 90 count, NDC 00093-0011-98
    • Pantoprazole tablet, Torrent, 20 mg, 90 count, NDC 13668-0096-90
    • Pantoprazole tablet, Torrent, 40 mg, 90 count, NDC 13668-0429-90

Estimated Resupply Dates

    • Actavis has pantoprazole 40 mg tablets on back order and the company cannot estimate a release date.
    • Kremers Urban is allocating pantoprazole 20 mg tablets weekly.
    • Teva has pantoprazole 40 mg tablets on intermittent back order and the company is releasing product as it becomes available.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 5, 2012 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins